BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15381370)

  • 1. Evolution of 8p loss in transformed human prostate epithelial cells.
    Macoska JA; Paris P; Collins C; Andaya A; Beheshti B; Chaib H; Kant R; Begley L; MacDonald JW; Squire JA
    Cancer Genet Cytogenet; 2004 Oct; 154(1):36-43. PubMed ID: 15381370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concordant copy number and transcriptional activity of genes mapping to derivative chromosomes 8 during cellular immortalization in vitro.
    Begley L; Keeney D; Beheshti B; Squire JA; Kant R; Chaib H; MacDonald JW; Rhim J; Macoska JA
    Genes Chromosomes Cancer; 2006 Feb; 45(2):136-46. PubMed ID: 16235240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haploinsufficiency and reduced expression of genes localized to the 8p chromosomal region in human prostate tumors.
    Chaib H; MacDonald JW; Vessella RL; Washburn JG; Quinn JE; Odman A; Rubin MA; Macoska JA
    Genes Chromosomes Cancer; 2003 Jul; 37(3):306-13. PubMed ID: 12759929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homozygous and frequent deletion of proximal 8p sequences in human prostate cancers: identification of a potential tumor suppressor gene site.
    Prasad MA; Trybus TM; Wojno KJ; Macoska JA
    Genes Chromosomes Cancer; 1998 Nov; 23(3):255-62. PubMed ID: 9790507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for three tumor suppressor gene loci on chromosome 8p in human prostate cancer.
    Macoska JA; Trybus TM; Benson PD; Sakr WA; Grignon DJ; Wojno KD; Pietruk T; Powell IJ
    Cancer Res; 1995 Nov; 55(22):5390-5. PubMed ID: 7585607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer.
    Macoska JA; Trybus TM; Sakr WA; Wolf MC; Benson PD; Powell IJ; Pontes JE
    Cancer Res; 1994 Jul; 54(14):3824-30. PubMed ID: 8033102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescence in situ hybridization evaluation of chromosome deletion patterns in prostate cancer.
    Huang SF; Xiao S; Renshaw AA; Loughlin KR; Hudson TJ; Fletcher JA
    Am J Pathol; 1996 Nov; 149(5):1565-73. PubMed ID: 8909246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of a small region around the PTEN locus is a major chromosome 10 alteration in prostate cancer xenografts and cell lines.
    Hermans KG; van Alewijk DC; Veltman JA; van Weerden W; van Kessel AG; Trapman J
    Genes Chromosomes Cancer; 2004 Mar; 39(3):171-84. PubMed ID: 14732919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The consequences of chromosomal aneuploidy on gene expression profiles in a cell line model for prostate carcinogenesis.
    Phillips JL; Hayward SW; Wang Y; Vasselli J; Pavlovich C; Padilla-Nash H; Pezullo JR; Ghadimi BM; Grossfeld GD; Rivera A; Linehan WM; Cunha GR; Ried T
    Cancer Res; 2001 Nov; 61(22):8143-9. PubMed ID: 11719443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletion.
    Bethel CR; Faith D; Li X; Guan B; Hicks JL; Lan F; Jenkins RB; Bieberich CJ; De Marzo AM
    Cancer Res; 2006 Nov; 66(22):10683-90. PubMed ID: 17108105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homozygous deletions within the 11q13 cervical cancer tumor-suppressor locus in radiation-induced, neoplastically transformed human hybrid cells.
    Mendonca MS; Farrington DL; Mayhugh BM; Qin Y; Temples T; Comerford K; Chakrabarti R; Zainabadi K; Redpath JL; Stanbridge EJ; Srivatsan ES
    Genes Chromosomes Cancer; 2004 Apr; 39(4):277-87. PubMed ID: 14978789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5q11, 8p11, and 10q22 are recurrent chromosomal breakpoints in prostate cancer cell lines.
    Pan Y; Lui WO; Nupponen N; Larsson C; Isola J; Visakorpi T; Bergerheim US; Kytölä S
    Genes Chromosomes Cancer; 2001 Feb; 30(2):187-95. PubMed ID: 11135436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion mapping of chromosome 8p in prostate cancer by fluorescence in situ hybridization.
    Matsuyama H; Pan Y; Skoog L; Tribukait B; Naito K; Ekman P; Lichter P; Bergerheim US
    Oncogene; 1994 Oct; 9(10):3071-6. PubMed ID: 8084616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of a consistent 4.5-megabase deletion at 4q28 in prostate cancer cells.
    Matsui S; LaDuca J; Rossi MR; Nowak NJ; Cowell JK
    Cancer Genet Cytogenet; 2005 May; 159(1):18-26. PubMed ID: 15860352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlating breakage-fusion-bridge events with the overall chromosomal instability and in vitro karyotype evolution in prostate cancer.
    Vukovic B; Beheshti B; Park P; Lim G; Bayani J; Zielenska M; Squire JA
    Cytogenet Genome Res; 2007; 116(1-2):1-11. PubMed ID: 17268171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The t(6;16)(p21;q22) chromosome translocation in the LNCaP prostate carcinoma cell line results in a tpc/hpr fusion gene.
    Veronese ML; Bullrich F; Negrini M; Croce CM
    Cancer Res; 1996 Feb; 56(4):728-32. PubMed ID: 8631004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-resolution analysis of genomic alteration on chromosome arm 8p in urothelial carcinoma.
    Williams SV; Platt FM; Hurst CD; Aveyard JS; Taylor CF; Pole JC; Garcia MJ; Knowles MA
    Genes Chromosomes Cancer; 2010 Jul; 49(7):642-59. PubMed ID: 20461757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candidate tumor-suppressor genes on chromosome arm 8p in early-onset and high-grade breast cancers.
    Armes JE; Hammet F; de Silva M; Ciciulla J; Ramus SJ; Soo WK; Mahoney A; Yarovaya N; Henderson MA; Gish K; Hutchins AM; Price GR; Venter DJ
    Oncogene; 2004 Jul; 23(33):5697-702. PubMed ID: 15184884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human beta-defensin-1, a potential chromosome 8p tumor suppressor: control of transcription and induction of apoptosis in renal cell carcinoma.
    Sun CQ; Arnold R; Fernandez-Golarz C; Parrish AB; Almekinder T; He J; Ho SM; Svoboda P; Pohl J; Marshall FF; Petros JA
    Cancer Res; 2006 Sep; 66(17):8542-9. PubMed ID: 16951166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of heterozygosity analysis and DNA copy number measurement on 8p in bladder cancer reveals two mechanisms of allelic loss.
    Adams J; Williams SV; Aveyard JS; Knowles MA
    Cancer Res; 2005 Jan; 65(1):66-75. PubMed ID: 15665280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.